The global market for inhalable drugs reached a size of USD 33.81 billion in 2022 and is projected to grow to USD 62.16 billion by 2032, with a compound annual growth rate (CAGR) of 7% during the forecast period. The primary driver of this growth is the increasing incidence of chronic respiratory conditions. According to […]
